Medicare Enrolled

Dr. Hugo Lin, M.D.

Endocrinology · Pittsburgh, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
10922 FRANKSTOWN RD, Pittsburgh, PA 15235
4122416111
In practice since 2008 (18 years)
NPI: 1134382823 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lin

Dr. Hugo Lin is an endocrinology specialist in Pittsburgh, PA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Lin performed 1,224 Medicare services across 434 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lin received a total of $21,141 from 46 pharmaceutical and/or device companies across 1286 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 26% volume in PA $21,141 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,224
Medicare services
Top 26% in PA for endocrinology
434
Unique beneficiaries
$62
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~68 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
547 $61 $135
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
351 $38 $125
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
194 $62 $120
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
132 $133 $275
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$21,141
Total received (2018-2024)
Avg $3,020/year across 7 years
Top 16% in PA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
1,286
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,129 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12 (0.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,800
2023
$3,037
2022
$3,116
2021
$3,374
2020
$2,951
2019
$2,841
2018
$3,022

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Dexcom, Inc.
$794
Lilly USA, LLC
$324
Novo Nordisk Inc
$316
Amneal Pharmaceuticals LLC
$281
AstraZeneca Pharmaceuticals LP
$261
Boehringer Ingelheim Pharmaceuticals, Inc.
$243
Bayer Healthcare Pharmaceuticals Inc.
$152
ABBVIE INC.
$89
Novartis Pharmaceuticals Corporation
$64
Medtronic, Inc.
$52
Amphastar Pharmaceuticals, Inc.
$39
BETA BIONICS, INC.
$29
Alexion Pharmaceuticals, Inc.
$27
Xeris Pharmaceuticals, Inc.
$27
Ascendis Pharma Inc
$26
Abbott Laboratories
$24
Ascensia Diabetes Care Us Inc.
$19
PFIZER INC.
$18
Amgen Inc.
$15
Top 3 companies account for 51.2% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$5,238
AstraZeneca Pharmaceuticals LP
$2,883
SANOFI-AVENTIS U.S. LLC
$2,128
Lilly USA, LLC
$2,038
Dexcom, Inc.
$1,610
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,569
Amneal Pharmaceuticals LLC
$1,227
Bayer HealthCare Pharmaceuticals Inc.
$767
Merck Sharp & Dohme Corporation
$708
Bayer Healthcare Pharmaceuticals Inc.
$342
Medtronic MiniMed, Inc.
$333
Janssen Pharmaceuticals, Inc
$306
AbbVie, Inc.
$248
Amarin Pharma Inc.
$238
ABBVIE INC.
$149
Esperion Therapeutics, Inc.
$129
Amgen Inc.
$118
Medtronic, Inc.
$116
Abbott Laboratories
$106
Novartis Pharmaceuticals Corporation
$96
AbbVie Inc.
$76
CeQur Corporation
$75
Merck Sharp & Dohme LLC
$55
Amphastar Pharmaceuticals, Inc.
$39
Xeris Pharmaceuticals, Inc.
$39
Insulet Corporation
$37
Gemini Laboratories, LLC
$37
RECORDATI_RARE_DISEASES_INC.
$30
Radius Health, Inc.
$30
BETA BIONICS, INC.
$29
Horizon Therapeutics plc
$28
Alexion Pharmaceuticals, Inc.
$27
VIVUS, Inc.
$27
Ascendis Pharma Inc
$26
IBSA Pharma Inc.
$25
Mannkind Corporation
$24
Valeritas, Inc.
$23
Nevro Corp.
$23
Corcept Therapeutics
$21
Ultragenyx Pharmaceutical Inc.
$20
Aytu BioScience, Inc
$19
Ascensia Diabetes Care Us Inc.
$19
PFIZER INC.
$18
Tandem Diabetes Care, Inc.
$18
MannKind Corporation
$15
Kowa Pharmaceuticals America, Inc.
$14
Top 3 companies account for 48.5% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Androgel · BAQSIMI · CREON · CRYSViTA · CeQur Simplicity · DIABETES - DISEASE · Dexcom G6 Transmitter · ENTRESTO · EVENITY · EVERSENSE 365 SENSOR KIT (RETAIL) · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · HUMALOG · HUMULIN · HUMULIN U · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LOKELMA · Livalo · MINIMED 780G · MOUNJARO · MiniMed Connect · Minimed 530G · Minimed 670G System · NEXLETOL · NEXLIZET · Natesto · Omnia · Omnipod · Ozempic · PRALUENT · QSYMIA · RECORLEV · RETEVMO · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STEGLATRO · STRENSIQ · SYNTHROID · Saxenda · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · Tirosint · Tresiba · Tymlos · UBRELVY · UNITHROID · V-GO · Vascepa · Victoza · Wegovy · XARELTO · Xultophy 100/3.6 · iLet Bionic Pancreas · t-slim insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an endocrinology specialist in Pittsburgh?
Compare endocrinologists in the Pittsburgh area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
75
Per 100K population
6.0
County median income
$76,393
Nearest hospital
FORBES HOSPITAL
3.9 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Lin is a clinical cardiology specialist, with above-average Medicare volume (top 26% in PA), with low-engagement industry engagement in the top 16% of PA peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Lin experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Lin performed 547 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lin receive payments from pharmaceutical companies?
Yes. Dr. Lin received a total of $21,141 from 46 companies across 1,286 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lin's costs compare to other endocrinologists in Pittsburgh?
Dr. Lin's average Medicare payment per service is $62. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →